Get the Stockscreener App
157.47
2.31%
3.56
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $157.47, with a volume of 10.97M.
It is up +2.31% in the last 24 hours and down -3.30% over the past month.
See More
Previous Close:
$153.91
Open:
$154.16
24h Volume:
10.97M
Relative Volume:
1.16
Market Cap:
$371.98B
Revenue:
$89.33B
Net Income/Loss:
$21.81B
P/E Ratio:
17.52
EPS:
8.99
Net Cash Flow:
$18.06B
1W Performance:
+5.90%
1M Performance:
-3.30%
6M Performance:
-4.26%
1Y Performance:
+8.77%
1-Day Range:
$154.16
$159.44
1-Week Range:
$148.19
$159.44
52-Week Range:
$140.68
$169.90
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
157.47 | 371.98B | 89.33B | 21.81B | 18.06B | 8.99 |
|
LLY
Lilly Eli Co
|
839.96 | 677.40B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
172.99 | 316.82B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
58.08 | 293.24B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
110.86 | 216.19B | 51.72B | 11.94B | 13.81B | 5.88 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Obituary information for David Edward Johnson - Boldt Funeral Home & Cremation Services
3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now - The Motley Fool
Johnson & Johnson: 15% of AI Use Cases Deliver 80% of Value - PYMNTS.com
Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy - Yahoo Finance
Grego and Johnson on College Baseball Foundation Award Watch Lists - Ball State University Athletics
J&J expects tariff charge of $400M this year - Supply Chain Dive
Johnson & Johnson's Role in Strengthening Mexico and North America's Healthcare Ecosystem - U.S. Chamber of Commerce
Crime is nonpartisan and the blame game on crime in cities is wrong – on both sides - The Conversation
Johnson & Johnson Pivots Its AI Strategy - WSJ
T&F to Host 2025 Michael Johnson Invitational Over Weekend - baylorbears.com
How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock - Yahoo Finance
Tree crashes into Johnson Park - nujournal.com
Minium: Sofia Johnson Chose ODU Sight Unseen, And The Monarch Tennis Star Is So Glad She Did - Old Dominion Athletics
Lawyers seek second chance from Texas judge in Johnson & Johnson’s talcum case - Dallas News
Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025 - Yahoo Finance
Val Chmerkovskiy Admits Finding Time for Intimacy with Wife Jenna Johnson Is 'Hit or Miss' at Times (Exclusive) - People.com
Clacton: Three missing teens safeguarded from drug line - Essex Police
The Senate – A look at how Thune and Schumer are doing - Punchbowl News
Spadaro: Paying it forward is the Eagles' Way - Philadelphia Eagles
Furr, Johnson Added Women’s Basketball Staff - Arkansas Razorbacks
Men's Tennis: Cadets sweep VTSU Johnson for second time this season, strengthen hopes for Empire 8 Tournament berth - Norwich University Athletics
Which Colleen Hoover Books Are Becoming Movies? 'Verity' And More - Deadline
J&J’s electrophysiology sales dip amid slow Varipulse start - MedTech Dive
A dozen House Republicans fire warning shot to Mike Johnson on Medicaid cuts - Axios
Our culture of inclusion - Johnson & Johnson
Grassley, Johnson press DOJ IG to respond on whether ‘untasked’ undercover agents were present on Jan 6 - Fox News
Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet” - Yahoo Finance
Trump’s Tariff Threat for Drug imports Poses Big Political Risks - The New York Times
EPO meets with Johnson & Johnson - epo.org
Katherine Johnson | Biography, Education, Accomplishments, & Facts - Britannica
Obituary for Ken Johnson - Harvey Anderson & Johnson Funeral Home
The Atlantic Hires Jenna Johnson and Dan Zak as Senior Editors, and Tyler Austin Harper as Staff Writer - The Atlantic
Dow Giant Flexes With A Guidance Hike Despite Tariff Worries - Investor's Business Daily
Johnson & Johnson earnings beat estimates on strong cancer drug sales - The Economic Times
Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear – Jim Cramer Weighs In - Yahoo Finance
Johnson & Johnson estimates $400M impact from worldwide tariffs, largely in medtech - Fierce Biotech
Johnson & Johnson (NYSE:JNJ) Increases Dividend and Reports Strong Q1 Earnings Growth - Yahoo Finance
LEGACY IN FOCUS: Whitney Johnson, Women's Basketball - Morgan State University Athletics
Johnson & Johnson Earnings: Solid Innovation and Manageable Tariff Headwind - Morningstar
Johnson & Johnson expects $400M in tariff costs this year - MassDevice
Johnson & Johnson warns pharma tariffs could cause drug shortages - Financial Times
Negative effects of technology: Psychological, social, and health - Medical News Today
J&J pegs tariff costs at about $400M in 2025 - MedTech Dive
Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China - 5 EYEWITNESS NEWS
J&J beat on earnings, but tariffs still pressure pharma sector - Yahoo Finance
J&J completes first surgeries with Ottava robot - MedTech Dive
J&J keeps forecasts steady as pharma confronts tariff threat - BioPharma Dive
As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations - Fierce Pharma
Johnson & Johnson CEO warns US tariffs may disrupt drug supply - Reuters
Why Johnson & Johnson Stock Is Down After Earnings Beat Expectations - Barron's
Digital Marketing Grad Makes Data-Driven Decisions at Johnson & Johnson - Full Sail University
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
7.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):